Very/moderately anti-inflammatory | Neutral | Very/moderately pro-inflammatory | Trend | ||||
---|---|---|---|---|---|---|---|
Incident severe NAFLD | HR (95%CI) | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value |
Model 0 | 1.00 (Ref.) | 1.11 (0.98; 1.26) | 0.087 | 1.54 (1.33; 1.78) | < 0.001 | 1.24 (1.15; 1.33) | < 0.001 |
Model 1 | 1.00 (Ref.) | 1.11 (0.98; 1.26) | 0.097 | 1.49 (1.28; 1.72) | < 0.001 | 1.22 (1.13; 1.31) | < 0.001 |
Model 2 | 1.00 (Ref.) | 1.04 (0.92; 1.18) | 0.489 | 1.24 (1.08; 1.44) | 0.003 | 1.11 (1.03; 1.20) | 0.004 |
Model 3 | 1.00 (Ref.) | 1.03 (0.91; 1.16) | 0.649 | 1.19 (1.03; 1.38) | 0.020 | 1.09 (1.01; 1.17) | 0.024 |